Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsN/A

Early Detection of At-risk Septic Patients

Sponsor: University Hospital Southampton NHS Foundation Trust

NCT ID: NCT06253325

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Health checks and monitoring — no treatment given
Type of study
Observational (no treatment given)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Measuring tissue oxygenation (diagnostic test), Procalcitonin (diagnostic test), Mid-regional proadrenomedullin (diagnostic test), Hand-held video microscope (diagnostic test)
How long the study runs
Study runs about 19 months (dates as stated)
About the drug or intervention
Measuring tissue oxygenation — diagnostic test: Measuring oxygen content of arteries, capillaries and veins · Procalcitonin — diagnostic test: Blood test · Mid-regional proadrenomedullin — diagnostic test: Blood test looking at inflammation in the body · Hand-held video microscope — diagnostic test: A handheld video microscope that looks at blood flow through the capillaries of the tongue
Patient visit burden
Not specified by the sponsor
Type of study
Observing health over time
Ages
18 Years and over
Who
All
Number of participants
60
Started
2024-01-12
Last checked
2024-11

Plain English Summary

What is this study?

  • • Testing a new treatment for sepsis
  • • Clinical study - 60 participants
  • • The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with sepsis

Where?

  • • Southampton - University Hospital Southampton NHS Foundation Trust

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care.

More detail

The investigators intend to recruit 56 patients with suspected sepsis who attend the Emergency Department. The investigators want to use a device to monitor tissue oxygen levels when they first come into the Emergency Department as well as the change in tissue oxygen levels when a tourniquet is applied for 3 minutes. The investigators will take novel blood tests when the patient is having their routine bloods. Finally, the investigators will use a special camera to take specialised pictures of the small blood vessels under the tongue which will show blood flow through these vessels. The investigators will follow the recruited patients and determine if our extra data is better at determining who needs critical care. A significant proportion of patients may be too unwell or too distressed to consent to be part of this study. At the earliest opportunity, the investigators will ask patients when they have been stabilised and are able to give consent. If they say no, they will be removed from the study and their care will not be affected by this decision. The results could help us identify septic shock as early as possible so that these unwell patients are identified early and get the correct treatment they need. This could mean starting advanced treatments usually found in the Intensive Care Unit very early on in a patient's journey.

Sepsis

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Differential diagnosis which includes infection
  • ✓Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5
  • ✓Aged ≥18 years

Who cannot take part

  • ✗Traumatic injury
  • ✗Rockwood frailty score ≥6
  • ✗Critical care therapy previously believed to not be in patient's best interests
  • ✗Critical care therapies-initiated pre-hospital. Critical care therapies defined as:
  • ✗1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital...
See the full criteria
Inclusion Criteria: 1. Differential diagnosis which includes infection 2. Change in the quick Sequential Organ Failure Assessment (qSOFA) ≥2 or National Early Warning Score 2 (NEWS2) score ≥5 3. Aged ≥18 years Exclusion Criteria: 1. Traumatic injury 2. Rockwood frailty score ≥6 3. Critical care therapy previously believed to not be in patient's best interests 4. Critical care therapies-initiated pre-hospital. Critical care therapies defined as: 4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support 5. Advanced directive refusing critical care therapies. 6. Acute cardiac failure 7. Active gastrointestinal bleed 8. Massive pulmonary embolism 9. ICU admission declined by critical care team 10. Treated in an acute hospital \<6 hours before presentation to the Emergency Department

Where Is This Study? (1 UK site)

University Hospital Southampton NHS Foundation Trust

Southampton SO16 6YD, United Kingdom

Recruiting
Hospital R&D contact (matched)

Dr Mikayala King

researchmanagement@uhs.nhs.uk023 81208215

How to Get in Touch

James N Ward, BM

Sponsor contact

CONTACT

+447881967336 wardj@doctors.org.uk

Ahilanandan Dushianthan, PhD

Sponsor contact

CONTACT

+447903943418 a.dushianthan@soton.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2024-11